GB1386566A - Alpha-sulphobenzyl penicillin salts - Google Patents

Alpha-sulphobenzyl penicillin salts

Info

Publication number
GB1386566A
GB1386566A GB3147473A GB3147473A GB1386566A GB 1386566 A GB1386566 A GB 1386566A GB 3147473 A GB3147473 A GB 3147473A GB 3147473 A GB3147473 A GB 3147473A GB 1386566 A GB1386566 A GB 1386566A
Authority
GB
United Kingdom
Prior art keywords
salts
amine
penicillin
salt
sulphobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3147473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GB1386566A publication Critical patent/GB1386566A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB3147473A 1972-07-01 1973-07-02 Alpha-sulphobenzyl penicillin salts Expired GB1386566A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (enExample) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
GB1386566A true GB1386566A (en) 1975-03-12

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3147473A Expired GB1386566A (en) 1972-07-01 1973-07-02 Alpha-sulphobenzyl penicillin salts

Country Status (15)

Country Link
US (1) US3925357A (enExample)
JP (1) JPS5512435B2 (enExample)
AT (1) AT325206B (enExample)
AU (1) AU469986B2 (enExample)
BE (1) BE801588A (enExample)
CA (1) CA996548A (enExample)
CH (1) CH573435A5 (enExample)
CS (1) CS168036B2 (enExample)
DE (1) DE2332840A1 (enExample)
FR (1) FR2190414B1 (enExample)
GB (1) GB1386566A (enExample)
HU (1) HU166029B (enExample)
NL (1) NL7308048A (enExample)
PL (1) PL92969B1 (enExample)
SE (1) SE402916B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (enExample) * 1978-07-29 1980-02-13
EA007485B1 (ru) * 2001-02-24 2006-10-27 Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг Производные ксантина, способ их получения, фармацевтическая композиция на их основе и способ ее получения
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
EP3542801A1 (en) * 2007-08-17 2019-09-25 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) * 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
CN103816158A (zh) * 2008-08-15 2014-05-28 勃林格殷格翰国际有限公司 用于治疗fab-相关疾病的嘌呤衍生物
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
KR101927068B1 (ko) 2010-05-05 2018-12-10 베링거 인겔하임 인터내셔날 게엠베하 체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
KR20200028498A (ko) 2010-06-24 2020-03-16 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
HUE061596T2 (hu) 2011-07-15 2023-07-28 Boehringer Ingelheim Int Szubsztituált dimer kinazolin származék, annak elõállítása és alkalmazása az I. és II. típusú cukorbetegség kezelésére szolgáló gyógyszerkészítményekben
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
BR112018072401A2 (pt) 2016-06-10 2019-02-19 Boehringer Ingelheim International Gmbh combinações de linagliptina e metformina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (enExample) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
US3925357A (en) 1975-12-09
NL7308048A (enExample) 1974-01-03
CS168036B2 (enExample) 1976-05-28
BE801588A (fr) 1973-12-28
JPS5512435B2 (enExample) 1980-04-02
AU469986B2 (en) 1976-02-26
FR2190414A1 (enExample) 1974-02-01
FR2190414B1 (enExample) 1976-07-02
CA996548A (en) 1976-09-07
PL92969B1 (enExample) 1977-04-30
AU5760073A (en) 1975-01-09
HU166029B (enExample) 1974-12-28
JPS4925121A (enExample) 1974-03-06
AT325206B (de) 1975-10-10
SE402916B (sv) 1978-07-24
CH573435A5 (enExample) 1976-03-15
DE2332840A1 (de) 1974-01-17

Similar Documents

Publication Publication Date Title
GB1386566A (en) Alpha-sulphobenzyl penicillin salts
GB1276446A (en) Process for the preparation of bis-maleimides
GB1420549A (en) Process for the production of gold powder
GB1334834A (en) Production of aminomethylene phosphonic acids
GB1381363A (en) Secondary pigments
GB1389217A (en) Phenylglycine derivatives
GB1343527A (en) Amino-propanol derivatives
GB1158726A (en) Amino Acid Derivatives
GB1384982A (en) Process for preparing nomega-acyl basic amino acids
GB1198828A (en) Process for Preparing Pyrryl-(2)-Acetonitriles
GB1237352A (en) Substituted propylamines
ES447176A1 (es) Procedimiento para la preparacion de aminoacidos.
GB1449070A (en) Aminotetralins and use in inducing anesthesia
GB1377674A (en) Tetracycline complex
GB1490558A (en) Phenylethylamine derivatives
GB1407742A (en) Preptide compounds and methods for their production
GB1380274A (en) Amino acid derivatives
GB1345645A (en) Diamido amino sulphonates and preparation thereof
ES407722A1 (es) Procedimiento para la preparacion de derivados de la 3h-1,-5-benzodiacepina.
GB1410339A (en) Process for the preparation of amides
GB1324022A (en) Purification of tetracycline antibiotics
GB1430695A (en) Process for the preparation of propargylamine
GB1477263A (en) Thiamindisulphidemono-orotate and process for its preparation
GB1305860A (enExample)
GB1417820A (en) Process for the production of guanidine salts of aliphatic mercaptosulphonic acids

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee